Valerie Huang

Valerie Huang has extensive experience in corporate development and strategy consulting. Valerie began their career in 2015 as an Associate Principal at ClearView Healthcare Partners, a strategy consulting firm focused exclusively on the life sciences industry. In 2020, they took on roles at SV Health Investors as a Venture Fellow, Denali Therapeutics as a Corporate Development, and CAMP4 Therapeutics as Business Development & Portfolio Strategy. Most recently, in 2021, they became the Director of Corporate Development at Cajal Neuroscience.

Valerie Huang attended Yale University from 2011 to 2015, graduating with a Bachelor of Arts in Economics. Valerie then attended The London School of Economics and Political Science (LSE) before pursuing their Master of Business Administration (MBA) at the MIT Sloan School of Management, which they are expected to complete in 2021.